Palisade Bio Investor Relations Material
Latest events
Q1 2025
11 May, 2025
Q4 2024
24 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Palisade Bio Inc
Access all reports
Palisade Bio Inc is a U.S.-based clinical-stage biopharmaceutical company developing therapeutics for gastrointestinal health. The company focuses on reducing post-surgical complications and improving recovery outcomes through targeted enzyme inhibitors. It collaborates with research institutions and conducts clinical trials to advance its drug candidates. The company is headquartered in Carlsbad, California, and its shares are listed on the NASDAQ.
Latest articles
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
Ticker symbol
PALI
Country
🇺🇸 United States